DeepNewz Markets

Markets Stories

Search

Loading...

Browse all stories on DeepNewz

CHMP Recommends Approval of Ionis and AstraZeneca's Wainzua for Rare Polyneuropathy

Oct 21, 2024, 06:10 AM

The Committee for Medicinal Products for Human Use (CHMP) in the EU has recommended the approval of Wainzua (eplontersen), a treatment developed by Ionis Pharmaceuticals and AstraZeneca, for adult patients with stage 1 or stage 2 polyneuropathy associated with hereditary transthyretin-mediated amyloidosis. This recommendation marks a significant step forward for patients suffering from this rare condition.

View original story

Markets

Loading...

Looking for markets...

Will the European Commission approve Wainzua by the end of 2024?

EU•Ionis Pharmaceuticals•AstraZeneca

Resolution / Starting Odds

Yes • 50%

No • 50%

Official announcement from the European Commission or press release from Ionis Pharmaceuticals or AstraZeneca

Will the FDA approve Wainzua by mid-2025?

EU•Ionis Pharmaceuticals•AstraZeneca

Resolution / Starting Odds

No • 50%

Yes • 50%

FDA official website or press release from Ionis Pharmaceuticals or AstraZeneca

Will Wainzua be listed as a reimbursable medicine in the EU by Q1 2025?

EU•Ionis Pharmaceuticals•AstraZeneca

Resolution / Starting Odds

No • 50%

Yes • 50%

Official EU publications or announcements from Ionis Pharmaceuticals or AstraZeneca

How many non-EU countries will approve Wainzua by the end of 2025?

EU•Ionis Pharmaceuticals•AstraZeneca

Resolution / Starting Odds

11-15 countries • 25%

0-5 countries • 25%

More than 15 countries • 25%

6-10 countries • 25%

Official announcements from national health authorities or press releases from Ionis Pharmaceuticals or AstraZeneca

What will be Wainzua's market share in the EU by the end of 2025?

EU•Ionis Pharmaceuticals•AstraZeneca

Resolution / Starting Odds

More than 60% • 25%

40% to 60% • 25%

Less than 20% • 25%

20% to 40% • 25%

Market analysis reports from reputable sources like IMS Health or company financial disclosures

Which EU country will first approve Wainzua by Q1 2025?

EU•Ionis Pharmaceuticals•AstraZeneca

Resolution / Starting Odds

Spain • 25%

Germany • 25%

France • 25%

Italy • 25%

Official announcements from national health authorities or press releases from Ionis Pharmaceuticals or AstraZeneca